Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trung N Tran

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 27, 2023
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthmaLuis Perez-de-Llano, Ghislaine Scelo, G Walter Canonica, et al.
Tuberculosis and Respiratory Diseases|February 6, 2025
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress UpdateDésirée Larenas-Linnemann, Chin Kook Rhee, Alan Altraja, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 20, 2024
Exploring Definitions and Predictors of Response to Biologics for Severe AsthmaGhislaine Scelo, Trung N Tran, Tham T Le, et al.
Journal of Asthma and Allergy|October 28, 2022
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic TherapyWenjia Chen, Mohsen Sadatsafavi, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 6, 2022
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe AsthmaCeleste M Porsbjerg, Andrew N Menzies-Gow, Trung N Tran, et al.
American Journal of Respiratory and Critical Care Medicine|May 3, 2024
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in AdultsLuis Perez-de-Llano, Ghislaine Scelo, Trung N Tran, et al.
Allergy|March 17, 2023
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for bothPaul E Pfeffer, Nasloon Ali, Ruth Murray, et al.
Allergy|June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohortEve Denton, Mark Hew, Matthew J Peters, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2023
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma RegistryWenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 27, 2023
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthmaLuis Perez-de-Llano, Ghislaine Scelo, G Walter Canonica, et al.
Tuberculosis and Respiratory Diseases|February 6, 2025
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress UpdateDésirée Larenas-Linnemann, Chin Kook Rhee, Alan Altraja, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 20, 2024
Exploring Definitions and Predictors of Response to Biologics for Severe AsthmaGhislaine Scelo, Trung N Tran, Tham T Le, et al.
Journal of Asthma and Allergy|October 28, 2022
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic TherapyWenjia Chen, Mohsen Sadatsafavi, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 6, 2022
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe AsthmaCeleste M Porsbjerg, Andrew N Menzies-Gow, Trung N Tran, et al.
American Journal of Respiratory and Critical Care Medicine|May 3, 2024
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in AdultsLuis Perez-de-Llano, Ghislaine Scelo, Trung N Tran, et al.
Allergy|March 17, 2023
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for bothPaul E Pfeffer, Nasloon Ali, Ruth Murray, et al.
Allergy|June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohortEve Denton, Mark Hew, Matthew J Peters, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2023
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma RegistryWenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
Pageof 9